ClearPoint Neuro (CLPT) Share-based Compensation (2011 - 2026)

ClearPoint Neuro has disclosed Share-based Compensation across 15 years of filings, most recently posting $2.2 million for Q1 2026.

• Share-based Compensation for Q1 2026 came in at $2.2 million, up 16.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.5 million (up 16.13% YoY), and the FY2025 annual result was $8.2 million, up 18.43% from the prior year.
• Share-based Compensation came in at $2.2 million for Q1 2026 at ClearPoint Neuro, up from $2.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $2.3 million in Q2 2025 to a low of $880000.0 in Q2 2022.
• The 5-year median for Share-based Compensation is $1.6 million (2023), against an average of $1.6 million.
• Across the five-year window, Share-based Compensation surged 256.28% in 2022 and rose 6.2% in 2025, its largest moves.
• ClearPoint Neuro's Share-based Compensation stood at $1.2 million in 2022, then jumped by 31.66% to $1.5 million in 2023, then advanced by 10.37% to $1.7 million in 2024, then climbed by 16.32% to $2.0 million in 2025, then grew by 11.96% to $2.2 million in 2026.
• The last three Share-based Compensation figures came in at $2.2 million (Q1 2026), $2.0 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.